MLB: Angels INF Luis Rengifo (wrist) returns to 10-day IL

Date:

Share post:


For the second time this season, the Los Angeles Angels placed infielder Luis Rengifo on the 10-day injured list on Saturday due to right wrist inflammation.

In a corresponding move, the Angels selected the contract of infielder Charles LeBlanc from Triple-A Salt Lake.

Rengifo, 27, was removed from Wednesday’s game against the Colorado Rockies due to a wrist flare-up, then sat out Thursday against the Rockies. He returned to the lineup on Friday against the New York Mets but exited after four innings due to the wrist issue.

He spent nearly three weeks on the IL after he first injured his wrist on July 3.

He was batting .315 before the initial wrist injury. He returned to action 20 days later and has since gone 6-for-32 (.188) in nine games with his average falling 15 points. In 78 games this season, he is hitting .300 with six home runs and 30 RBIs.

Over six seasons (526 games) with the Angels, Rengifo is a .253 hitter with 53 home runs and 187 RBIs.

LeBlanc was batting .262 with 12 homers and 48 RBIs in 81 games at Salt Lake this season. The 28-year-old played 48 games for the Miami Marlins in 2022 and batted .263 with four homers and 11 RBIs in 48 games.

–Field Level Media

spot_img

Related articles

MLB: Mariners trade for Cubs INF/OF Miles Mastrobuoni

The Seattle Mariners acquired utility player Miles Mastrobuoni from the Chicago Cubs on Tuesday for cash considerations. In a...

MLB: Police: Former Orioles P Brian Matusz likely died from overdose

The cause of death of former Baltimore Orioles pitcher Brian Matusz likely is a drug overdose, The Baltimore...

MLB: Reports: Japanese RHP Roki Sasaki rules out Yanks, Mets

Roki Sasaki's window to sign with a major league team opens Wednesday, but the coveted Japanese right-hander has...

MLB: Mariners sign INF Donovan Solano to one-year deal

The Seattle Mariners signed veteran infielder Donovan Solano to a one-year contract on Monday. According to a published report,...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.